If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimo Siciliano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Ribavirin Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Genotype Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2019 2019

Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population: The effect of Male sex on survival of C9Orf72 positive patients

Trojsi, F., Siciliano, M., Femiano, C., Santangelo, G., Lunetta, C., Calvo, A., Moglia, C., Marinou, K., Ticozzi, N., Ferro, C., Scialò, C., Sorarù, G., Conte, A., Falzone, Y. M., Tortelli, R., Russo, M., Sansone, V. A., Chiò, A., Mora, G., Silani, V. & 11 others, Volanti, P., Caponnetto, C., Querin, G., Sabatelli, M., Riva, N., Logroscino, G., Messina, S., Fasano, A., Monsurrò, M. R., Tedeschi, G. & Mandrioli, J., 2019, In : Frontiers in Neuroscience. 13, MAY

Research output: Contribution to journalArticle

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study

Lionetti, R., Piccolo, P., Lenci, I., Siciliano, M., Visco-Comandini, U., De Santis, A., Pompili, M., Milana, M., Taibi, C., Dell'Isola, S., Montalbano, M., Mastroianni, C., Begini, P., Garbuglia, A. R., Angelico, M. & D'Offizi, G., May 1 2019, In : Annals of Hepatology. 18, 3, p. 434-438 5 p.

Research output: Contribution to journalArticle

Open Access
Ribavirin
Hepatitis C
Fibrosis
Genotype
Gastroenterology

Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?

HepatoCATT Study Group for the Multidisciplinary Management of HCC, May 2019, In : European Journal of Radiology. 114, p. 32-37 6 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Hemorrhage
Control Groups
Therapeutics
Safety